Healthcare - Biotechnology - NYSE - US
$ 6.37
-12.9 %
$ 367 M
Market Cap
-0.35
P/E
INCOME STATEMENT
251 M
REVENUE
-864 M
OPERATING INCOME
-893 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Ginkgo Bioworks Holdings, Inc.
| Revenue | 251 M |
| Cost Of Revenue | 54 M |
| Gross Profit | 197 M |
| Operating Expenses | 1.11 B |
| Operating Income | -864 M |
| Other Expenses | 28.5 M |
| Net Income | -893 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2001 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 251.5 | 477.7 | 313.8 | 76.7 | 54.2 | 98.3 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 54.0 | 204.2 | 129.7 | 15.6 | 0 | 0 |
| Gross Profit | 197.4 | 273.5 | 184.1 | 61.0 | 54.2 | 98.3 |
| OPERATING INCOME | ||||||
| Operating Expenses | 1 108.4 | 2 482.4 | 2 012.6 | 198.1 | 125.8 | 177.9 |
| Selling, General and Administrative Expenses | 385.0 | 1 429.8 | 863.0 | 38.3 | 29.5 | 77.4 |
| Research and Development Expenses | 580.6 | 1 052.6 | 1 149.7 | 159.8 | 96.3 | 100.5 |
| Operating Income | (864.4) | (2 209.0) | (1 828.5) | (137.0) | (71.6) | (234.5) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 93 K | 0.1 | 2.4 | 2.4 | 2.4 | 0 |
| Total Other Income | (28.5) | 87.6 | (9.7) | 12.2 | (48.2) | 0 |
| Pre-Tax Income | (892.9) | (2 121.4) | (1 838.1) | (124.8) | (119.8) | 0 |
| NET INCOME | ||||||
| Tax Provision | 71 K | (15.0) | (1.5) | 1.9 | 22 K | 0 |
| Net Income | (892.9) | (2 104.9) | (1 830.0) | (126.6) | (119.3) | 0 |
| EPS | 18.4 | 50.1 | 53.8 | 0.0853 | 0.0804 | 0 |